These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
278 related articles for article (PubMed ID: 35205851)
21. Lung epithelial and myeloid innate immunity in influenza-associated or COVID-19-associated pulmonary aspergillosis: an observational study. Feys S; Gonçalves SM; Khan M; Choi S; Boeckx B; Chatelain D; Cunha C; Debaveye Y; Hermans G; Hertoghs M; Humblet-Baron S; Jacobs C; Lagrou K; Marcelis L; Maizel J; Meersseman P; Nyga R; Seldeslachts L; Starick MR; Thevissen K; Vandenbriele C; Vanderbeke L; Vande Velde G; Van Regenmortel N; Vanstapel A; Vanmassenhove S; Wilmer A; Van De Veerdonk FL; De Hertogh G; Mombaerts P; Lambrechts D; Carvalho A; Van Weyenbergh J; Wauters J Lancet Respir Med; 2022 Dec; 10(12):1147-1159. PubMed ID: 36029799 [TBL] [Abstract][Full Text] [Related]
22. COVID-19-associated pulmonary aspergillosis in patients with severe SARS-CoV-2 infection: A single-center observational study from Greece. Ouranos K; Tsakiri K; Massa E; Dourliou V; Mouratidou C; Soundoulounaki S; Mouloudi E Ann Thorac Med; 2023; 18(3):116-123. PubMed ID: 37663880 [TBL] [Abstract][Full Text] [Related]
23. COVID-19-associated invasive pulmonary aspergillosis in a tertiary care center in Mexico City. Vélez Pintado M; Camiro-Zúñiga A; Aguilar Soto M; Cuenca D; Mercado M; Crabtree-Ramirez B; Med Mycol; 2021 Jul; 59(8):828-833. PubMed ID: 33724423 [TBL] [Abstract][Full Text] [Related]
24. A Tale of Two Hospitals: Comparing CAPA Infections in Two ICUs During the Spanish Fourth Pandemic Wave. Sánchez-Castellano MÁ; Marcelo C; Marco J; Figueira-Iglesias JC; García-Rodríguez J Mycopathologia; 2023 Aug; 188(4):335-344. PubMed ID: 37256502 [TBL] [Abstract][Full Text] [Related]
25. COVID-Associated Pulmonary Aspergillosis and Its Related Outcomes: A Single-Center Prospective Observational Study. Iqbal A; Ramzan M; Akhtar A; Ahtesham A; Aslam S; Khalid J Cureus; 2021 Aug; 13(8):e16982. PubMed ID: 34527462 [TBL] [Abstract][Full Text] [Related]
26. Risk Factors for Invasive Aspergillosis in Patients Admitted to the Intensive Care Unit With Coronavirus Disease 2019: A Multicenter Retrospective Study. Xu J; Yang X; Lv Z; Zhou T; Liu H; Zou X; Cao F; Zhang L; Liu B; Chen W; Yu Y; Shu H; Yuan S; Hu M; Huang C; Shang Y Front Med (Lausanne); 2021; 8():753659. PubMed ID: 34869450 [No Abstract] [Full Text] [Related]
27. Usefulness of Sōna Aspergillus Galactomannan LFA with digital readout as diagnostic and as screening tool of COVID-19 associated pulmonary aspergillosis in critically ill patients. Data from a multicenter prospective study performed in Argentina. Giusiano G; Fernández NB; Vitale RG; Alvarez C; Ochiuzzi ME; Santiso G; Cabeza MS; Tracogna F; Farías L; Afeltra J; Noblega LM; Giuliano CV; Garcia-Effron G Med Mycol; 2022 May; 60(5):. PubMed ID: 35394043 [TBL] [Abstract][Full Text] [Related]
28. Association between Pulmonary Aspergillosis and Caciagli V; Coloretti I; Talamonti M; Farinelli C; Gatto I; Biagioni E; Sarti M; Franceschini E; Meschiari M; Mussini C; Tonelli R; Clini E; Girardis M; Busani S; Modena Covid-Working Group Viruses; 2023 Nov; 15(11):. PubMed ID: 38005936 [TBL] [Abstract][Full Text] [Related]
29. Challenges in Diagnosing COVID-19-Associated Pulmonary Aspergillosis in Critically Ill Patients: The Relationship between Case Definitions and Autoptic Data. Casalini G; Giacomelli A; Galimberti L; Colombo R; Ballone E; Pozza G; Zacheo M; Galimberti M; Oreni L; Carsana L; Longo M; Gismondo MR; Tonello C; Nebuloni M; Antinori S J Fungi (Basel); 2022 Aug; 8(9):. PubMed ID: 36135619 [TBL] [Abstract][Full Text] [Related]
31. COVID-19-associated pulmonary aspergillosis (CAPA): Risk factors and development of a predictive score for critically ill COVID-19 patients. Calderón-Parra J; Mills-Sanchez P; Moreno-Torres V; Tejado-Bravo S; Romero-Sánchez I; Balandin-Moreno B; Calvo-Salvador M; Portero-Azorín F; García-Masedo S; Muñez-Rubio E; Ramos-Martinez A; Fernández-Cruz A; Mycoses; 2022 May; 65(5):541-550. PubMed ID: 35212030 [TBL] [Abstract][Full Text] [Related]
32. COVID-19 associated Pulmonary Aspergillosis in Patients Admitted to the Intensive Care Unit: Impact of Antifungal Prophylaxis. Frost J; Gornicec M; Reisinger AC; Eller P; Hoenigl M; Prattes J Mycopathologia; 2024 Jan; 189(1):3. PubMed ID: 38217742 [TBL] [Abstract][Full Text] [Related]
33. Antifungal prophylaxis for prevention of COVID-19-associated pulmonary aspergillosis in critically ill patients: an observational study. Hatzl S; Reisinger AC; Posch F; Prattes J; Stradner M; Pilz S; Eller P; Schoerghuber M; Toller W; Gorkiewicz G; Metnitz P; Rief M; Prüller F; Rosenkranz AR; Valentin T; Krause R; Hoenigl M; Schilcher G Crit Care; 2021 Sep; 25(1):335. PubMed ID: 34526087 [TBL] [Abstract][Full Text] [Related]
34. Invasive pulmonary aspergillosis in critically ill patients with severe COVID-19 pneumonia: Results from the prospective AspCOVID-19 study. Lahmer T; Kriescher S; Herner A; Rothe K; Spinner CD; Schneider J; Mayer U; Neuenhahn M; Hoffmann D; Geisler F; Heim M; Schneider G; Schmid RM; Huber W; Rasch S PLoS One; 2021; 16(3):e0238825. PubMed ID: 33730058 [TBL] [Abstract][Full Text] [Related]
35. COVID-19-associated pulmonary aspergillosis (CAPA) in patients admitted with severe COVID-19 pneumonia: An observational study from Pakistan. Nasir N; Farooqi J; Mahmood SF; Jabeen K Mycoses; 2020 Aug; 63(8):766-770. PubMed ID: 32585069 [TBL] [Abstract][Full Text] [Related]
36. Nebulized Amphotericin B in Mechanically Ventilated COVID-19 Patients to Prevent Invasive Pulmonary Aspergillosis: A Retrospective Cohort Study. Melchers M; van Zanten ARH; Heusinkveld M; Leeuwis JW; Schellaars R; Lammers HJW; Kreemer FJ; Haas PJ; Verweij PE; van Bree SHW Crit Care Explor; 2022 May; 4(5):e0696. PubMed ID: 35558738 [TBL] [Abstract][Full Text] [Related]
37. Potential links between COVID-19-associated pulmonary aspergillosis and bronchiectasis as detected by high resolution computed tomography. Baratella E; Roman-Pognuz E; Zerbato V; Minelli P; Cavallaro MFM; Cova MA; Luzzati R; Lucangelo U; Sanson G; Friso F; Bussani R; Pinamonti M; Busetti M; Salton F; Confalonieri M; Ruaro B; Di Bella S Front Biosci (Landmark Ed); 2021 Dec; 26(12):1607-1612. PubMed ID: 34994174 [TBL] [Abstract][Full Text] [Related]
38. Risk factors for invasive aspergillosis in ICU patients with COVID-19: current insights and new key elements. Montrucchio G; Lupia T; Lombardo D; Stroffolini G; Corcione S; De Rosa FG; Brazzi L Ann Intensive Care; 2021 Sep; 11(1):136. PubMed ID: 34524562 [TBL] [Abstract][Full Text] [Related]
39. Incidence and Risk Factors of COVID-19-Associated Pulmonary Aspergillosis in Intensive Care Unit-A Monocentric Retrospective Observational Study. Gregoire E; Pirotte BF; Moerman F; Altdorfer A; Gaspard L; Firre E; Moonen M; Fraipont V; Ernst M; Darcis G Pathogens; 2021 Oct; 10(11):. PubMed ID: 34832526 [TBL] [Abstract][Full Text] [Related]
40. COVID-19-associated aspergillosis in a Brazilian referral centre: Diagnosis, risk factors and outcomes. de Almeida JN; Doi AM; Watanabe MJL; Maluf MM; Calderon CL; Silva M; Pasternak J; Koga PCM; Santiago KAS; Aranha LFC; Szarf G; da Silva Teles GB; Filippi RZ; Paes VR; Baeta M; Hamerschlak N; Mangueira CLP; Martino MDV Mycoses; 2022 Apr; 65(4):449-457. PubMed ID: 35174567 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]